A phase 3 trial of cytisine for the treatment of smoking cessation.
Phase of Trial: Phase III
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Cytisine (Primary)
- Indications Smoking withdrawal
- Focus Registrational; Therapeutic Use
- Sponsors Achieve Life Sciences
- 09 Nov 2017 According to an Achieve Life Sciences media release, the study is expected to initiate in mid-2018.
- 30 Oct 2017 According to an Achieve Life Sciences media release, phase 3 plans will be presented at VirtualInvestorConferences.com on November 2, 2017.
- 16 Aug 2017 New trial record